These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 33322052)
41. Apigenin analogues as SARS-CoV-2 main protease inhibitors: Farhat A; Ben Hlima H; Khemakhem B; Ben Halima Y; Michaud P; Abdelkafi S; Fendri I Bioengineered; 2022 Feb; 13(2):3350-3361. PubMed ID: 35048792 [TBL] [Abstract][Full Text] [Related]
42. An Updated Review on SARS-CoV-2 Main Proteinase (M Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134 [TBL] [Abstract][Full Text] [Related]
43. Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19. Rai H; Barik A; Singh YP; Suresh A; Singh L; Singh G; Nayak UY; Dubey VK; Modi G Mol Divers; 2021 Aug; 25(3):1905-1927. PubMed ID: 33582935 [TBL] [Abstract][Full Text] [Related]
44. Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with M J A; Francis D; C S S; K G A; C S; Variyar EJ J Biomol Struct Dyn; 2022 Jan; 40(1):325-336. PubMed ID: 32873185 [TBL] [Abstract][Full Text] [Related]
45. Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies. Diniz LRL; Perez-Castillo Y; Elshabrawy HA; Filho CDSMB; de Sousa DP Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33430299 [TBL] [Abstract][Full Text] [Related]
46. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591 [TBL] [Abstract][Full Text] [Related]
47. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease. Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462 [TBL] [Abstract][Full Text] [Related]
48. Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach. Kanhed AM; Patel DV; Teli DM; Patel NR; Chhabria MT; Yadav MR Mol Divers; 2021 Feb; 25(1):383-401. PubMed ID: 32737681 [TBL] [Abstract][Full Text] [Related]
49. Integrated bioinformatics-cheminformatics approach toward locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro. Swain SS; Singh SR; Sahoo A; Panda PK; Hussain T; Pati S Proteins; 2022 Sep; 90(9):1617-1633. PubMed ID: 35384056 [TBL] [Abstract][Full Text] [Related]
50. Bung N; Krishnan SR; Bulusu G; Roy A Future Med Chem; 2021 Mar; 13(6):575-585. PubMed ID: 33590764 [No Abstract] [Full Text] [Related]
51. DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M Chamakuri S; Lu S; Ucisik MN; Bohren KM; Chen YC; Du HC; Faver JC; Jimmidi R; Li F; Li JY; Nyshadham P; Palmer SS; Pollet J; Qin X; Ronca SE; Sankaran B; Sharma KL; Tan Z; Versteeg L; Yu Z; Matzuk MM; Palzkill T; Young DW Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34426525 [TBL] [Abstract][Full Text] [Related]
52. Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CL Liu WS; Li HG; Ding CH; Zhang HX; Wang RR; Li JQ Aging (Albany NY); 2021 Mar; 13(5):6258-6272. PubMed ID: 33678621 [TBL] [Abstract][Full Text] [Related]
54. Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors. Breidenbach J; Lemke C; Pillaiyar T; Schäkel L; Al Hamwi G; Diett M; Gedschold R; Geiger N; Lopez V; Mirza S; Namasivayam V; Schiedel AC; Sylvester K; Thimm D; Vielmuth C; Phuong Vu L; Zyulina M; Bodem J; Gütschow M; Müller CE Angew Chem Int Ed Engl; 2021 Apr; 60(18):10423-10429. PubMed ID: 33655614 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach. El Bakri Y; Anouar EH; Ahmad S; Nassar AA; Taha ML; Mague JT; El Ghayati L; Essassi EM Appl Biochem Biotechnol; 2021 Nov; 193(11):3602-3623. PubMed ID: 34324152 [TBL] [Abstract][Full Text] [Related]
57. Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 M Ahamad S; Kanipakam H; Birla S; Ali MS; Gupta D Eur J Pharmacol; 2021 Jan; 890():173664. PubMed ID: 33131721 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of phytoconstituents of Choudhary P; Singh T; Amod A; Singh S J Biomol Struct Dyn; 2023 Jun; 41(9):4106-4123. PubMed ID: 35467486 [TBL] [Abstract][Full Text] [Related]
59. Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches. Raj V; Park JG; Cho KH; Choi P; Kim T; Ham J; Lee J Int J Biol Macromol; 2021 Jan; 168():474-485. PubMed ID: 33290767 [TBL] [Abstract][Full Text] [Related]